Eric Lefkofsky, Tempus founder and CEO (Photo by Michael Kovac/Getty Images)

Tem­pus founders build a drug dis­cov­ery start­up, Pathos AI, with $40M in sight

Ex­ec­u­tives be­hind AI and pre­ci­sion med­i­cine start­up Tem­pus are putting to­geth­er an­oth­er AI out­fit in Chica­go fo­cused on on­col­o­gy drug dis­cov­ery and de­vel­op­ment.

Pathos AI is cur­rent­ly in the works and at­tempt­ing to raise about $40 mil­lion, per an SEC fil­ing from this week. List­ed on the pa­per­work are Tem­pus CEO Er­ic Lefkof­sky and op­er­at­ing chief Ryan Fukushi­ma, who is de­scribed as CEO of Pathos. Lefkof­sky co-found­ed Groupon, is a trustee of many mar­quee Chica­go in­sti­tu­tions and co-man­ages the Mid­west VC firm Light­bank, which is cur­rent­ly look­ing to raise $250 mil­lion for its third fund, per an­oth­er doc­u­ment filed with the SEC last No­vem­ber.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.